logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure DUP-2. Prevalence of lifetime injecting drug use among prisoners


Data were not available for the un-listed EU Member States.
Data between brackets refer to size of the sample and year of the study.
The numbering after the country name refer to the number of the source in Table DUP-0.
Belgium: Data refer to adult prisoners, including remanded, sentenced and mentally disordered prisoners, both males and females.
Hungary: Data refer to adult males only.
United Kingdom: Data refer to females only.
Data for Bulgaria, Germany, Latvia, (a) Hungary, and (a) Portugal refer to prevalence lifetime injecting drug use prior to imprisonment.
Data for (b) Hungary, (b) Portugal and Rumania refer to prevalence lifetime injecting drug use prior/inside prison.

Related links:

Statistical bulletin 2009: Figure DUP-2 part (i)
For methodological information, please refer to Table DUP-1.
For access to sources and bibliographic references, please refer to Table DUP-0.
See also 'General notes for interpreting data' on the Explanatory notes and help page.


Reitox national focal points.

(see the help page for information about formats etc.)

Page last updated: Wednesday, 15 July 2009